MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Hypertrophic Olivary Degeneration

    G. Moreno, K. Ng, A. Duffy (Sacramento, CA, USA)

    Objective: We report the findings of a patient presenting with palatal myoclonus (PM) several months after suffering from an Intracranial Hemorrhage (ICH) in order to…
  • 2017 International Congress

    Pattern of MRI findings in ephedronic encephalopathy

    M. Okujava, F. Todua, M. Janelidze, I. Khatiashvili (Tbilisi, Georgia)

    Objective: Objective of  the study was to summarize the typical neuroradiological picture of ephedronic encephalopathy and its clinical correlates. Background: Methcathinone (Ephedrone, Jeff etc.) emerged as…
  • 2017 International Congress

    Onabotulinumtoxin A (Botox) displays superior activity to incobotulinumtoxinA (Xeomin) in multiple in vitro and in vivo assays

    D. Canty, L. Le, J. Wang, G. Nicholson, A. Brideau-Andersen, L. Steward, B. Jacky, R. Broide, M. Washburn, D. Rupp (Irvine, CA, USA)

    Objective: This study was conducted to assess in vivo and in vitro activity of 50 U, 100 U, and 200 U vials of incobotulinumtoxinA (Merz,…
  • 2017 International Congress

    Neuroprotective effects of antidepressant mirtazapine against dopaminergic neurodegeneration in cultured cells and in parkinsonian mice possibly by targeting astrocytes

    M. Asanuma, I. Miyazaki, R. Kikuoka, S. Murakami, N. Isooka, Y. Kitamura (Okayama, Japan)

    Objective: In this study, we examined neuroprotective effects of mirtazapine and involvement of astrocytes in the effects using primary cultured cells and parkinsonian mice. Background:…
  • 2017 International Congress

    Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

    H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)

    Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
  • 2017 International Congress

    Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

    Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)

    Objective: To clarify clinical features of patients with progressive mild cognitive impairment patients (MCI) in Parkinson’s disease (PD-MCI). Background: Non-demented PD subjects have MCI and…
  • 2017 International Congress

    Defective visual perception in patients with Lewy body disease: assessment of hallucinations with pareidolia test.

    Y. Higashi, T. Tabuchi, M. Tabata (Himeji, Japan)

    Objective: Hallucination is a common feature in patients with advanced Parkinson’s disease(PD) and dementia with Lewy bodies (DLB). Background: The pareidolia test is a tool…
  • 2017 International Congress

    Apolipoprotein E ε4 allele frequency in Korean Patients with Parkinson’s disease Dementia

    M. Park (Daegu, Republic of Korea)

    Objective: The Apo E allele frequencies were evaluated in Korean patients with probable PDD diagnosed by the MDS task force criteria for the diagnosis of…
  • 2017 International Congress

    The Effect of Anxiety on Cognition in Parkinson’s Disease

    S. Anderson, G. Stebbins, B. Bernard, A. Negron, J. Goldman (Chicago, IL, USA)

    Objective: Our study examined the effect of anxiety on cognition in Parkinson’s disease (PD) patients without cognitive impairment, mild cognitive impairment and dementia. Background: Anxiety…
  • 2017 International Congress

    CLOCK rs1801260 polymorphism is associated with suscepibilty of Parkinson’s disease in Chinese population

    F. Lou, X. Luo, M. Li, Y. Ren (Shenyang, China)

    Objective: This study is aimed at evaluating the potential association between the single-nucleotide polymorphism of two functional clock genes (CLOCK gene rs1801260 and PER2 gene…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 155
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley